Johnson & Johnson and Intra-Cellular Therapies, Inc. announced today that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback